Navigation Links
PDL BioPharma Announces Second Quarter 2013 Financial Results
Date:8/8/2013

INCLINE VILLAGE, Nev., Aug. 8, 2013  /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the second quarter and six months ended June 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

Royalty revenues for the second quarter of 2013 increased 14 percent to $143.6 million from $125.9 million reported in the second quarter of 2012. For the first six months of 2013, royalty revenues increased 16 percent to $235.5 million from $203.2 million reported in the comparable period of 2012.

Royalty revenues for the second quarter of 2013 are based on first quarter 2013 product sales by PDL's licensees. The royalty revenue growth year to date is driven by increased sales by PDL's licensees in the fourth quarter of 2012 and first quarter of 2013 of Avastin®, Herceptin®, Lucentis®, Perjeta®, Kadcyla®, Tysabri®, and Actemra®.  Net sales of Avastin, Herceptin, Lucentis, Xolair, Perjeta, and Kadcyla are subject to a tiered royalty rate except in the case when the product is ex-U.S. Manufactured and Sold, in which case it is subject to a flat three percent royalty rate.

General and administrative expenses for the second quarter of 2013 were $6.8 million, compared with $5.1 million in the same quarter of 2012. For the six months ended June 30, 2013, general and administrative expenses were $14.0 million compared to $12.1 million in the comparable period of 2012. The increase in expenses for both the quarter and six months ended June 30, 2013, was a result of increased legal expenses related to litigation.

Net income for the second quarter of 2013 was $93.7 million, or $0.62 per diluted share, as
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... According to a new market ... Trends & Forecasts (2015-2020) , published by Mordor Intelligence, ... 2.85 billion by the end of 2020, with ... globally accounting for more than 36% of the global ... expected to grow at a CAGR of 44.6% during ...
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... with its OmniPod ® Insulin Management System, today ... appointed to Insulet,s Board of Directors. Dr. ... experience to the Insulet Board. She currently serves as ... Diabetes Center, the world,s largest diabetes research center, diabetes ...
(Date:7/28/2015)... 28, 2015   Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended June 30, 2015 on Tuesday, August ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its second quarter 2015 ...
Breaking Medicine Technology:New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 2New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3
(Date:7/29/2015)... ... 2015 , ... HealthPostures ( https://healthpostures.com ), a sit stand ... ergonomics specialty firm. Purpose of the partnership is to help strengthen and expand ... worker mobility, functionality and fitness levels. , Executives at HealthPostures and 247Ergo ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune ... a chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. ... that children can enjoy to maintain a healthy balance of beneficial gut bacteria,” ...
(Date:7/28/2015)... (PRWEB) , ... July 29, 2015 , ... ... C-Level executives, doctors, lawyers and other A-Listers, has evolved into a world class ... Meet a Millionaire strives to match successful and attractive people seeking real, meaningful ...
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or ... This would allow insurers to access the on-board vehicle data and better understand customer ... it comes to sharing vehicle data. However times are changing and automakers realize that ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its ... a row, Dr. Francisco Canales and Dr. Heather Furnas took the top spot as the ... Dr. Furnas and Dr. Canales are proud to be bestowed such a prestigious title. ...
Breaking Medicine News(10 mins):Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2
... that might one day be used to block the ... disease. Their experiments offer not an immediate cure, but ... the development of this relentless neurodegenerative disorder. Huntington,s ... mutation in a single gene and marked by progressive ...
... drink warm milk or listen to soothing music, many insomniacs probably ... sleep. Scientists at Washington University School of Medicine in St. ... flies. In a study appearing June 24 in Science, ... the brains of fruit flies controls when and how long the ...
... 23 (HealthDay News) -- Being married improves the likelihood of ... Married men and women with colon cancer were 14 percent ... to U.S. researchers who analyzed 127,753 patient records. The ... stages of colon cancer and sought more aggressive treatment, which ...
... makes a happy meal? Many people ... the contribution this behavior makes to the current obesity ... system circuits that control it. Insight into this could ... curb this potentially detrimental behavior. In this context, a ...
... THURSDAY, June 23 (HealthDay News) -- Cocaine contaminated with levamisole, ... could result in a U.S. public health epidemic, experts warn. ... in an upcoming print issue of the Journal of ... in Los Angeles and New York who smoked or snorted ...
... latest works by some of Singapore,s leading writers and ... spotlight at The Contemporary, an international conference of literature ... (NTU). Presented by the University,s Division ... Social Sciences (CLASS) programme, The Contemporary conference will feature ...
Cached Medicine News:Health News:A step toward controlling Huntington's disease? 2Health News:A step toward controlling Huntington's disease? 3Health News:Sleep switch found in fruit flies 2Health News:JCI table of contents: June 23, 2011 2Health News:JCI table of contents: June 23, 2011 3Health News:JCI table of contents: June 23, 2011 4Health News:JCI table of contents: June 23, 2011 5Health News:JCI table of contents: June 23, 2011 6Health News:JCI table of contents: June 23, 2011 7Health News:Tainted Cocaine Tied to Severe Skin Reactions 2Health News:NTU hosts landmark conference on contemporary literature and the arts 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
S.O.C. Medium...
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
Medicine Products: